The Affordability and Accessibility of Ontario's Publicly Funded IVF Program: A Survey of Patients

Shawn P Winsor1, Kari Ala-Leppilampi2, Karen Spitzer3

  • 1Joint Centre for Bioethics, University of Toronto, Toronto, ON; Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, ON.

Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|December 18, 2019
PubMed
Abstract

Insights

The Ontario Fertility Program improved in vitro fertilization (IVF) affordability for many, but geographic inequities and inconsistent patient prioritization persist. Further evaluation is needed to enhance access and address remaining challenges in fertility treatment.

Area of Science:

  • Reproductive Medicine
  • Health Policy and Economics

Background:

  • The Ontario Fertility Program was established in 2015 to fund one cycle of in vitro fertilization (IVF).
  • The program aimed to increase IVF affordability and accessibility for Ontarians under 43.

Purpose of the Study:

  • To evaluate the Ontario Fertility Program's effectiveness based on patient experiences.
  • To identify program strengths, weaknesses, and areas for improvement in IVF access and affordability.

Main Methods:

  • An electronic survey was distributed to patients via IVF clinics and fertility websites.
  • The survey was conducted in late 2017, with 514 participants completing over 75% of it.

Main Results:

  • Patients reported decreased financial inequities and a lower opportunity cost for accessing IVF.
  • Identified weaknesses include lack of transparency in clinic prioritization, geographic inequities in access, and high ancillary costs.
  • Suggestions for improvement included funding more than one IVF cycle, standardizing prioritization, and means testing.

Conclusions:

  • Patients strongly support the program and acknowledge improved IVF affordability.
  • However, reliance on private clinics has perpetuated geographic inequities and inconsistent prioritization.
  • Findings will inform policymakers on re-evaluating funding and improving IVF provision and access.

Related Concept Videos

Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
3.6K
In Vitro Fertilization01:24

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
818
Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
492
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
108